Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jorge Alatorre Alexander"'
Autor:
Rafal Dziadziuszko, Nir Peled, Tony Mok, Solange Peters, Santiago Ponce Aix, Jorge Alatorre-Alexander, Brian D. Vicuna, Margaret Maclennan, Vijay Bhagawati-Prasad, Sarah M. Shagan, Erica Schleifman, Thorsten Ruf, Michael S. Mathisen, Shirish M. Gadgeel
Publikováno v:
Contemporary Oncology, Vol 27, Iss 4, Pp 217-223 (2024)
Externí odkaz:
https://doaj.org/article/de66fd03358a49bbbdeaeff487884027
Autor:
Jinming Yu, Andrea Ardizzoni, Delvys Rodriguez-Abreu, Sergio Azevedo, Belen Rubio-Viqueira, Jorge Alatorre-Alexander, Hans J M Smit, Konstantinos Syrigos, Jonathan Tolson, Thomas Newsom-Davis, Elen Höglander, Monika Kaul, Youyou Hu, Hans Kristian Vollan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 11 (2022)
In patients with previously treated advanced or metastatic non-small cell lung cancer (NSCLC), atezolizumab therapy improves survival with manageable safety. The open-label, single-arm phase III/IV TAIL study (NCT03285763) evaluated atezolizumab mono
Externí odkaz:
https://doaj.org/article/2ceefc7fcfd74dd3adcd680ddc725cbc
Autor:
Jinming Yu, Andrés Cardona, Andrea Ardizzoni, Delvys Rodriguez-Abreu, Sergio Azevedo, Belen Rubio-Viqueira, Jorge Alatorre-Alexander, Hans J M Smit, Konstantinos Syrigos, Kerstin Trunzer, Hina Patel, Jonathan Tolson, Pablo D Perez-Moreno
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)
Background Atezolizumab treatment improves survival, with manageable safety, in patients with previously treated advanced/metastatic non-small cell lung cancer. The global phase III/IV study TAIL (NCT03285763) was conducted to evaluate the safety and
Externí odkaz:
https://doaj.org/article/ff460346035746668e4d5b72630465b6
Autor:
Feliciano Barrón-Barrón, Enrique Guzmán-De Alba, Jorge Alatorre-Alexander, Fernando Aldaco-Sarvide, Yolanda Bautista-Aragón, Mónica Blake-Cerda, Yazmín Carolina Blanco-Vázquez, Saúl Campos-Gómez, José Francisco Corona-Cruz, Marco Antonio Iñiguez-García, Francisco Javier Lozano-Ruiz, Federico Maldonado-Magos, Dolores de la Mata-Moya, Luis Manuel Martínez-Barrera, Rubí Ramos-Prudencio, Jerónimo Rodríguez-Cid, Samuel Rivera-Rivera, Raúl Rogelio Trejo-Rosales, Marco Rodrigo Aguilar-Ortíz, Horacio Astudillo-de la Vega, Luis Javier Barajas-Figueroa, Nimbe Barroso-Quiroga, Andrés Blanco-Salazar, Graciano Castillo-Ortega, Luis Manuel Domínguez-Parra, María Isabel Enriquez-Aceves, Armando Fernández-Orozco, Marco Antonio Figueroa-Morales, León Green-Schneewiss, Jorge Alejandro González-Garay, Rogelio González Ramírez-Benfield, Alberto Guadarrama-Orozco, Jorge Guerrero-Ixtlahuac, David Hernández-Barajas, Raymundo Hernández-Montes de Oca, Javier Kelly-García, Miguel Lázaro-León, Fernando Silva-Bravo, Jóse Luis Tellez-Becerra, Eleazar Omar Macedo-Pérez, Gibert Maza-Ramos, José Luis Mayorga-Butrón, Bertha Beatriz Montaño-Velázquez, Karina Murillo-Medina, Salvador Narváez-Fernández, Francisco Javier Ochoa-Carrillo, Guillermo Olivares-Beltrán, Carlos Olivares-Torres, Mario Ponce de León-Castillo, Mario Alberto Ponce-Viveros, Jaime Ernesto Rubio-Gutiérrez, Julia Angelina Sáenz-Frías, Jorge Alberto Silva-Vivas, Patricio Santillán-Doherty, Juan José Soto-Ávila, Vinicio Toledo-Buenrostro, Benito Vargas-Abrego, Liliana Velasco-Hidalgo, Marta Margarita Zapata-Tarres, Gregorio Quintero-Beuló, Oscar Arrieta
Publikováno v:
Salud Pública de México, Vol 61, Iss 3, may-jun, Pp 359-414 (2019)
Resumen. El cáncer de pulmón es una de las principales causas de mortalidad alrededor del mundo. Su historia natural, con la manifestación de síntomas en etapas avanzadas y el retraso en su diagnóstico hacen que una gran proporción de pacientes
Externí odkaz:
https://doaj.org/article/78d5b6a752f744b3ac20179875d931a6
Autor:
Melissa L, Johnson, Byoung Chul, Cho, Alexander, Luft, Jorge, Alatorre-Alexander, Sarayut Lucien, Geater, Konstantin, Laktionov, Sang-We, Kim, Grygorii, Ursol, Maen, Hussein, Farah Louise, Lim, Cheng-Ta, Yang, Luiz Henrique, Araujo, Haruhiro, Saito, Niels, Reinmuth, Xiaojin, Shi, Lynne, Poole, Solange, Peters, Edward B, Garon, Tony, Mok
Publikováno v:
Journal of Clinical Oncology. 41:1213-1227
PURPOSE The open-label, phase III POSEIDON study evaluated tremelimumab plus durvalumab and chemotherapy (T + D + CT) and durvalumab plus chemotherapy (D + CT) versus chemotherapy alone (CT) in first-line metastatic non–small-cell lung cancer (mNSC
Autor:
Luis Gabriel Vázquez-Lavista, Luis Llorente, Jorge Alatorre-Alexander, José Arturo Ramírez-Muciño
Publikováno v:
Urology Case Reports, Vol 33, Iss , Pp 101350- (2020)
We present a case of a 69 year old man with phimosis associated with immunotherapy with durvalumab for metastatic non-small-cell lung cancer. The patient developed vitiligo like dermatosis after the induction dose of durvalumab, subsequent administra
Externí odkaz:
https://doaj.org/article/884fafb6f43d47ba8feb86cad64f0faf
Autor:
Luis A. Cabrera-Miranda, Diego A. Díaz-García, José F. Corona-Cruz, Francisco J. Lozano-Ruiz, Roberto Sánchez-Reyes, Mario E. Álvarez-Bojórquez, Mónica Blake-Cerda, Raúl Rivera-Márquez, Raúl A. López-Saucedo, Sandra I. Pérez-Álvarez, Laura M. Bolaño-Guerra, Jorge Alatorre-Alexander, Francisco Alexander-Meza, Feliciano Barrón-Barrón, Yazmin Blanco-Vázquez, Saúl Campos-Gómez, Dolores de la Mata-Moya, Pedro Figueroa-Martínez, Paulina E. González-Cisneros, Marco A. Iñíguez-García, Jesús M. Lázaro-León, Ulises Loyola-García, Marcelino Morales-Rivera, Carlos Olivares-Torres, Maritza Ramos-Ramírez, Julia A. Sáenz-Frías, Fernando Silva-Bravo, Rogelio Trejo-Rosales, Miguel Souto-del Bosque, Óscar Arrieta
Publikováno v:
Gaceta Mexicana de Oncolog�a.
Guía de práctica clínica para el manejo del cáncer de pulmón de células pequeñas: enfermedad extensa
Autor:
Luis A. Cabrera-Miranda, Diego A. Díaz-García, José F. Corona-Cruz, Francisco J. Lozano-Ruiz, Roberto Sánchez-Reyes, Mario E. Álvarez-Bojórquez, Mónica Blake-Cerda, Raúl Rivera-Márquez, Raúl A. López-Saucedo, Sandra I. Pérez-Álvarez, Laura M. Bolaño-Guerra, Jorge Alatorre-Alexander, Francisco Alexander-Meza, Feliciano Barrón-Barrón, Yazmin Blanco-Vázquez, Saúl Campos-Gómez, Dolores de la Mata-Moya, Pedro Figueroa-Martínez, Paulina E. González-Cisneros, Marco A. Iñíguez-García, Jesús M. Lázaro-León, Ulises Loyola-García, Marcelino Morales-Rivera, Carlos Olivares-Torres, Maritza Ramos-Ramírez, Julia A. Sáenz-Frías, Fernando Silva-Bravo, Rogelio Trejo-Rosales, Miguel Souto-del Bosque, Óscar Arrieta
Publikováno v:
Gaceta Mexicana de Oncolog�a.
Autor:
Hugh Montgomery, F D Richard Hobbs, Francisco Padilla, Douglas Arbetter, Alison Templeton, Seth Seegobin, Kenneth Kim, Jesus Abraham Simón Campos, Rosalinda H Arends, Bryan H Brodek, Dennis Brooks, Pedro Garbes, Julieta Jimenez, Gavin C K W Koh, Kelly W Padilla, Katie Streicher, Rolando M Viani, Vijay Alagappan, Menelas N Pangalos, Mark T Esser, Wakana Abe, Tania Adan De Varona, Daria Adiatullina, Daniel Aguilar Zapata, Kevin Ahlers, Carolina Aimo, Ayoade Akere, Elena Akimova, Jorge Alatorre Alexander, Logan Aldrich, Ismael Ali Garcia, Karim Ali García, Lee Allison, Rosa Alonso Zuñiga, Ivan Aloysius, Javier Altclas, Andres Alvarisqueta, Martti Antila, Camila Anton, Elisabet Árboix Alamo, Samir Arora, Ramón Alejandro Avilés Felix, Natalya Bakhtina, Varenka Barbero-Becerra, Armando Barragan-Reyes, Alejandro Barreira, Mitchell Barrett, Jiri Beran, Nikolett Berki, Viktoria Berki, Richard Betten, Claudia Binelli, Lenka Brunzová, Cecilia Bussolari, Karianna Byargeon, Justyna Bytnar, Carlos Camberos, Pedro Campos Corzo, Grazia Cannon, Valentina Canovi, Simone Carla da Rosa, Ana Caroline Moser, Luis Carrera Rivas, Marcelo Martin Casas, Paulo Castañeda-Méndez, Ana Cavalcante, Eugenia Cherepova, Alexei Chermenskii, Lauren Clark, Mauro Codeluppi, Flavia Coelho, Belinda Contreras, Alex Cran, Taylor Dao, Chrisette Dharma, Cosimo Di Castri, Victoria Diaz Balocchi, Omar Durán, Kara Earl, Adam Ellery, Tomoko Endo, Andrea Everding, Rainald Fischer, Benedito Fonseca, Chelsea C. Franklin, Susan-Beatrice Franz, Anna Fumagalli, Mauricio Galindo-Amaya, Mariagiulia Galli, Laura Gerna, Karolly Gil Ureña, Henrikki Gomes Antila, Laura Ines Gomes Maricato, Gabriela Goncalvez, Martin Gonzalez, Jesús González-Lama, Stephen Granier, Jacob Granier, Stephan Grunwald, David Guardeño-Ropero, Monica Guberti, Sridhar Guduri, Carolina Guerrero García, Jehad Haggiagi, Kacie Hale, Toshimasa Hayashi, Maiara Hermes, Dante Hernandez Colin, Yuji Hirai, Masayuki Hojo, Tetsuya Homma, Billy Hour, Andreas Huber, Diego Iacovelli, Noriomi Ishibashi, Yutaro Iwabe, Shinyu Izumi, Arne Jessen, Heiko Jessen, Wilner Jeudy, Marta Jiménez Marcos, Rebecca Johnson, Eva Juárez-Hernández, Kiyomi Kabasawa, Katarzyna Kamińska, Megumi Kawabe, Angela Kemp, Oleg Khmelnitskiy, Carina Klassen, Olena Kobrynska, Pavel Koleckar, Stephanie Korn, Marc Kornmann, Viktor Kostenko, Evgenii Kovalchuk, Yana Kovalchuk, Tim Kümmerle, Ulrike Lachmund, Kerstin Lammersmann, Flávio Lastebasse, Ivana Lattuada, Felicitas Lauer, Kyrylo Lebed, Olga Lebed, Diego Lecona-Garcia, Maria Christina Leoni, Marina Lima, Raymond Little, Holly Little, Andrea Lizardi-Díaz, Michele Lobo-Becker, Francesco Luppi, Veronica Macias, Shigefumi Maesaki, Cristiano Magnaghi, Annalisa Mancini, Stanisław Mazur, Tatiana Melnikova, Sergio Menchaca, Ibrahim Menendez-Perez, Ewa Międlar, Shuuichi Mizunuma, Anastasiya Mochalova, Mihad Mohamed, Theresa Moll, Camila Montalvo, Amber Mottola, Birgit Mück, Rebeca Mussi Brugnolli, Akanksha Nanda, Dörthe Neuner, Agatha Ngwueke, Sebastian Noe, Martin Novacek, Laura Nuzzolo-Shihadeh, Emeka Obiekwe, Isaias G. Ocampo Gaytán, Norio Ohmagari, Shin Ohta, Ptuonye Onyewuchi, Iurii Pankov, Maurício Pedrosa, Yael Peré, Alejandro Pereyra, Eliana Perez, Eduardo Perez-Alba, Paloma Perpiña Lozano, Tanya Perrei, Dena Peterson, Ligia Pierroti, Felipe Pineda-Cárdenas, Teresa Plascencia Sanchez, Camila Poletti, Chiara Pomaranzi, Lisette Portes, Nils Postel, Monica Ramirez, Isabel Ramírez, Miguel Ramirez-Baena, Mahadev Ramjee, Giovanna Ratti, Jackie Reeve, Petr Reichert, Petra Reichertová, Edgar Alejandro Reyes Garcia, Celso Ricardo, Nicomedes Rodríguez Rodríguez, Jaun Roldán Sánchez, Matilde Romero-Lopez, Tyrone Rosales, Harvey Rosales, Mohamed Roshan, Simran Roshan, Patrizia Rovere Querini, Heather Rutter, Sadaf Sachwani, Hironori Sagara, Jun Sakai, Nina Samson, José Héctor Sánchez Mijangos, Liliana Sánchez, Ana Sánchez-González, Micko Sandford, Laura Santana, Felipe Santos de Carvalho, Reiko Sasao, Lubna Sato, Elizabeth Scheuermann, Olaf Schmidt, Masafumi Seki, Safia Shaikh, Daishi Shimada, Masaharu Shinkai, Masahiro Shinoda, Jackie Smith, Fernando Solorzano, Silvia Soncini, Katalin Soregine, Erica Sosa, Olalekan Sowade, Veronika Špinková, Ruth Staniford, Iska Steigemann, Vivien Steiner, Vladimir Strelkov, Cintya R. Suárez Pineda, Hiroki Suenaga, Shintaro Suzaki, Hannah Swayze, Yuji Tada, Yuichiro Takeshita, Yasuo Takiguchi, Akihiko Tanaka, Norihito Tarumoto, Albina Tatarintseva, Michelle Taubert, Elizaveta Terenya, César Tinoco, Tomohiro Tomiyasu, Gladys Torres-Vidal, Gabriela Trejo-Aguiar, Kenji Tsushima, Emma Tunstall, Caterina Turrà, Yoandy Valdes, Nelly Valencia Castro, Guilherme Visconti, Giordano Vitali, Apinya Vutikullird, Jezdancher Watti, Doreen Werth, Cheyanne Wilson, Philippe Wilson, Amy Workman, Pamela Wörle, Christoph Wyen, Yoshiko Yamaguchi, Kei Yamamoto
Background: Early intramuscular administration of SARS-CoV-2-neutralising monoclonal antibody combination, tixagevimab–cilgavimab, to non-hospitalised adults with mild to moderate COVID-19 has potential to prevent disease progression. We aimed to e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d94fa5ffbc73770cc232f4cba4d22465
https://ora.ox.ac.uk/objects/uuid:a692f8eb-aeed-49a1-a1a8-3275e433517b
https://ora.ox.ac.uk/objects/uuid:a692f8eb-aeed-49a1-a1a8-3275e433517b
Autor:
E Wesley Ely, Athimalaipet V Ramanan, Cynthia E Kartman, Stephanie de Bono, Ran Liao, Maria Lucia B Piruzeli, Jason D Goldman, José Francisco Kerr Saraiva, Sujatro Chakladar, Vincent C Marconi, Jorge Alatorre-Alexander, Javier David Altclas, Marcelo Casas, Valeria CevoliRecio, Todd Ellerin, Kleber Giovanni Luz, Jason D. Goldman, Maria Patelli Juliani Souza Lima, Akram Khan, Priscila Paulin, Ana Carolina Procopio Carvalho, Gustavo Rojas Velasco, Jose Francisco Kerr Saraiva, Imad Shawa, Jesus Simon Campos, Brian Tiffany, Adilson Westheimer Cavalcante
Publikováno v:
The Lancet. Respiratory Medicine
Background The oral, selective Janus kinase 1/2 inhibitor baricitinib has shown efficacy in studies of hospitalised adults with COVID-19. COV-BARRIER (NCT04421027) was a multinational, phase 3, randomised, double-blind, placebo-controlled trial of ba